Showing results (341-350 of 348) with videos related to
Sort By:
Pageof 35
You have reached the last page of results.This site can display upto 348 results.
Medicine|March 10, 2023
The efficacy and safety of combined GLP-1RA and basal insulin therapy among inadequately controlled T2D with premixed insulin therapyJhih-Syuan Liu, Sheng-Chiang Su, Feng-Chih Kuo, et al.Gene|December 26, 2012
Genetic diagnosis of autosomal dominant polycystic kidney disease by targeted capture and next-generation sequencing: utility and limitationsXiao-Ping Qi, Zhen-Fang Du, Ju-Ming Ma, et al.Plos One|May 2, 2024
The role of traditional Chinese medicine on fracture surgery, hospitalization, and total mortality risks in diabetic patients with osteoporosisYi-Chen Liu, Chi-Hsiang Chung, Chien-Jung Lin, et al.Journal of the Chinese Medical Association : JCMA|June 1, 2022
Dipeptidyl peptidase-4 inhibitors attenuates osteoporosis in patients with diabetes: A nationwide, retrospective, matched-cohort study in TaiwanChia-Hao Chang, Chieh Hua Lu, Chi-Hsiang Chung, et al.Cell Research|August 7, 2013
Genome analysis and signature discovery for diving and sensory properties of the endangered Chinese alligatorQiu-Hong Wan, Sheng-Kai Pan, Li Hu, et al.Medicine|February 10, 2025
Glucagon-like peptide-1 receptor agonists therapy to attenuate the risk of knee osteoarthritis and total knee replacement in type 2 diabetes mellitus: A nation-wide population-based cohort studyChih-Ping Lin, Chi-Hsiang Chung, Chieh-Hua Lu, et al.Blood|March 17, 2021
A composite single-nucleotide polymorphism prediction signature for extranodal natural killer/T-cell lymphomaXiao-Peng Tian, Shu-Yun Ma, Ken H Young, et al.Nature Communications|July 9, 2025
Clinical impact of pharmacogenetic risk variants in a large chinese cohortChun-Yu Wei, Ming-Shien Wen, Chih-Kuang Cheng, et al.Pageof 35